BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 26240512)

  • 1. In Vivo Effects of Preservative-free and Preserved Prostaglandin Analogs: Mouse Ocular Surface Study.
    Kim JH; Kim EJ; Kim YH; Kim YI; Lee SH; Jung JC; Lee KW; Park YJ
    Korean J Ophthalmol; 2015 Aug; 29(4):270-9. PubMed ID: 26240512
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The cytotoxic effects of preserved and preservative-free prostaglandin analogs on human corneal and conjunctival epithelium in vitro and the distribution of benzalkonium chloride homologs in ocular surface tissues in vivo.
    Pellinen P; Huhtala A; Tolonen A; Lokkila J; Mäenpää J; Uusitalo H
    Curr Eye Res; 2012 Feb; 37(2):145-54. PubMed ID: 22049909
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro effects of preservative-free and preserved prostaglandin analogs on primary cultured human conjunctival fibroblast cells.
    Kim EJ; Kim YH; Kang SH; Lee KW; Park YJ
    Korean J Ophthalmol; 2013 Dec; 27(6):446-53. PubMed ID: 24311931
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Toxicological evaluation of preservative-containing and preservative-free topical prostaglandin analogues on a three-dimensional-reconstituted corneal epithelium system.
    Liang H; Pauly A; Riancho L; Baudouin C; Brignole-Baudouin F
    Br J Ophthalmol; 2011 Jun; 95(6):869-75. PubMed ID: 21429894
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the Efficacy of Fluorometholone With and Without Benzalkonium Chloride in Ocular Surface Disease.
    Kim YH; Jung JC; Jung SY; Yu S; Lee KW; Park YJ
    Cornea; 2016 Feb; 35(2):234-42. PubMed ID: 26619385
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of benzalkonium chloride-preserved, polyquad-preserved, and sofZia-preserved topical glaucoma medications on human ocular epithelial cells.
    Ammar DA; Noecker RJ; Kahook MY
    Adv Ther; 2010 Nov; 27(11):837-45. PubMed ID: 20931366
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro study of inflammatory potential and toxicity profile of latanoprost, travoprost, and bimatoprost in conjunctiva-derived epithelial cells.
    Guenoun JM; Baudouin C; Rat P; Pauly A; Warnet JM; Brignole-Baudouin F
    Invest Ophthalmol Vis Sci; 2005 Jul; 46(7):2444-50. PubMed ID: 15980234
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of corneal and conjunctival changes after dosing of travoprost preserved with sofZia, latanoprost with 0.02% benzalkonium chloride, and preservative-free artificial tears.
    Kahook MY; Noecker RJ
    Cornea; 2008 Apr; 27(3):339-43. PubMed ID: 18362664
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of benzalkonium chloride in topical glaucoma treatment: An investigation of the efficacy and safety of benzalkonium chloride-preserved intraocular pressure-lowering eye drops and their effect on conjunctival goblet cells.
    Nagstrup AH
    Acta Ophthalmol; 2023 Dec; 101 Suppl 278():3-21. PubMed ID: 38037546
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ocular surface tolerability of prostaglandin analogs in patients with glaucoma or ocular hypertension.
    Whitson JT; Trattler WB; Matossian C; Williams J; Hollander DA
    J Ocul Pharmacol Ther; 2010 Jun; 26(3):287-92. PubMed ID: 20578283
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Toxicity evaluation of antiglaucoma drugs using stratified human cultivated corneal epithelial sheets.
    Nakagawa S; Usui T; Yokoo S; Omichi S; Kimakura M; Mori Y; Miyata K; Aihara M; Amano S; Araie M
    Invest Ophthalmol Vis Sci; 2012 Aug; 53(9):5154-60. PubMed ID: 22695966
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Corneal damage and its recovery after instillation of preservative-free versus preserved latanoprost eye drops.
    Inoue D; Mohamed YH; Uematsu M; Kitaoka T
    Cutan Ocul Toxicol; 2020 Jun; 39(2):158-164. PubMed ID: 32295438
    [No Abstract]   [Full Text] [Related]  

  • 13. In vitro comparison of cytoprotective and antioxidative effects of latanoprost, travoprost, and bimatoprost on conjunctiva-derived epithelial cells.
    Guenoun JM; Baudouin C; Rat P; Pauly A; Warnet JM; Brignole-Baudouin F
    Invest Ophthalmol Vis Sci; 2005 Dec; 46(12):4594-9. PubMed ID: 16303954
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the cytotoxic effects of ophthalmic solutions containing benzalkonium chloride on corneal epithelium using an organotypic 3-D model.
    Khoh-Reiter S; Jessen BA
    BMC Ophthalmol; 2009 Jul; 9():5. PubMed ID: 19638217
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparing the effect of benzalkonium chloride-preserved, polyquad-preserved, and preservative-free prostaglandin analogue eye drops on cultured human conjunctival goblet cells.
    Hedengran A; Freiberg J; May Hansen P; Boix-Lemonche G; Utheim TP; Dartt DA; Petrovski G; Heegaard S; Kolko M
    J Optom; 2024; 17(1):100481. PubMed ID: 37788596
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Corneal epithelial cell viability following exposure to ophthalmic solutions containing preservatives and/or antihypertensive agents.
    Whitson JT; Petroll WM
    Adv Ther; 2012 Oct; 29(10):874-88. PubMed ID: 23065664
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the ocular surface changes following the use of two different prostaglandin F2α analogues containing benzalkonium chloride or polyquad in rabbit eyes.
    Lee HJ; Jun RM; Cho MS; Choi KR
    Cutan Ocul Toxicol; 2015; 34(3):195-202. PubMed ID: 25265260
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sodium hyaluronate decreases ocular surface toxicity induced by benzalkonium chloride-preserved latanoprost: an in vivo study.
    Yu F; Liu X; Zhong Y; Guo X; Li M; Mao Z; Xiao H; Yang S
    Invest Ophthalmol Vis Sci; 2013 May; 54(5):3385-93. PubMed ID: 23620425
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the ocular tolerability of a latanoprost cationic emulsion versus conventional formulations of prostaglandins: an in vivo toxicity assay.
    Liang H; Baudouin C; Faure MO; Lambert G; Brignole-Baudouin F
    Mol Vis; 2009 Aug; 15():1690-9. PubMed ID: 19710954
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of changing from preserved prostaglandins to preservative-free tafluprost in patients with glaucoma on tear film thickness.
    Hommer A; Schmidl D; Kromus M; Bata AM; Fondi K; Werkmeister RM; Baar C; Schmetterer L; Garhöfer G
    Eur J Ophthalmol; 2018 Jul; 28(4):385-392. PubMed ID: 29592773
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.